The Efficacy of a Probiotic for Antibiotic Associated Gastrointestinal Symptoms

NACompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

May 9, 2023

Primary Completion Date

July 25, 2024

Study Completion Date

July 25, 2024

Conditions
Antibiotic-associated Diarrhea
Interventions
DIETARY_SUPPLEMENT

Probiotic

Participants in this arm will receive a daily dose of 2x10\^9 Colony Forming Units (CFU) of a multi strain probiotic (live bacterium), corresponding to 2 capsules twice daily, for the duration of antibiotic therapy, and 14 days thereafter.

DIETARY_SUPPLEMENT

Placebo

Participants in this arm will receive an equivalent placebo for for the duration of antibiotic therapy, and 14 day thereafter.

Trial Locations (1)

10369

analyze & realize GmbH, Berlin

All Listed Sponsors
collaborator

Analyze & Realize

NETWORK

lead

The Archer-Daniels-Midland Company

INDUSTRY

NCT05845073 - The Efficacy of a Probiotic for Antibiotic Associated Gastrointestinal Symptoms | Biotech Hunter | Biotech Hunter